UNC study: shape, not just size, impacts effectiveness of emerging nanomedicine... (study's findings should prove of interes...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

UNC study: shape, not just size, impacts effectiveness of emerging nanomedicine therapies

Date:8/4/2008

study's findings should prove of interest to the biopharmaceutical industry.

"We are delighted to contribute to the important work that Professor DeSimone and his students are undertaking in the field of nanomedicine. This work answers key questions about the role of particle shape and size that industry leaders have been asking for some time," Fowler said.

'/>"/>

Contact: Patric Lane
patric_lane@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Study: verbal aggression may affect childrens behavior
2. UNC study: Common vaginal infection may increase risk of HIV infection
3. Brain cancer study: Magnitude of post-vaccine immune response linked to clinical outcomes
4. UNC study: Out-of-pocket health care costs for disabled children vary widely by state
5. Study: Global Business Performance Significantly Improved Through Project Management
6. Geisinger study: PTSD causes early death from heart disease
7. Study: 9/11 Dogs Suffered Few Health Effects
8. Study: Medicare Competitive Bidding Program Could Impede Seniors Access to Diabetes Testing Supplies
9. New NV Economic Study: Bush Medicare Cuts Undermine State and Local Economic, Jobs Base
10. Pharmaceutical study: Less hemorrhaging after stroke, but not fewer deaths
11. New PA Economic Study: Bush Medicare Cuts Compound State Medicaid Crisis

Post Your Comments:

Breaking Medicine News(10 mins):Health News:Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award 2 Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 2 Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 3 Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 2 Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 3 Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 2 Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 3 Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 4 Health News:Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn 2 Health News:Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn 3

[0] Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award [0] The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area [0] Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report [0] Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity [0] Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn

Other Medicine News:Health News:Trails to detect effective breast cancer drugs that reduces recurrences 2

Rip Off: Care Less about Medicare $90m Fraud Deals?Trails to detect effective breast cancer drugs that reduces recurrences New System To Isolate People Affected By Bird Flu Midwives demand that pregnant women should be made to pay for epidurals!Cancer Stems From Stem Cells?Anthrax Spores: Animal Skins on Drums, Renders Vado Diomande, Sick

Breaking Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2 TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13 Roper Industries Completes the Acquisition of Verathon, Inc. 2 Roper Industries Completes the Acquisition of Verathon, Inc. 3 delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation 9666 1 delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation 9666 2 Advances in lung cancer research announced at conference 55064 1 Advances in lung cancer research announced at conference 55064 2 Fecal DNA methylation detects gastric and colorectal cancers 55060 1 Fecal DNA methylation detects gastric and colorectal cancers 55060 2

[0] TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease [0] Helix BioPharma Corp. Announces Fiscal Q1 2010 Results [0] Roper Industries Completes the Acquisition of Verathon, Inc.

Other Medicine Technology:Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 2 Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 3 Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 4 Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 5 Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 6 Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 2 Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 3 Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 4

Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007

Medicine Products:

Cerner PowerChart Electronic Medical Record Medinformatix EncounterPRO Electronic Health Record MRAnywhere